AxoGen

AxoGen

Developing technologies for peripheral nerve regeneration and repair.

Launch date
Employees
Market cap
€541m
Enterprise valuation
€584m (Public information from Sep 2024)
Alachua Florida (HQ)
Authorizing premium user...